EP1766371A4 - Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime - Google Patents

Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime

Info

Publication number
EP1766371A4
EP1766371A4 EP05752221A EP05752221A EP1766371A4 EP 1766371 A4 EP1766371 A4 EP 1766371A4 EP 05752221 A EP05752221 A EP 05752221A EP 05752221 A EP05752221 A EP 05752221A EP 1766371 A4 EP1766371 A4 EP 1766371A4
Authority
EP
European Patent Office
Prior art keywords
measurement
molecular oxygen
fluorescence lifetime
glucose monitors
via molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05752221A
Other languages
German (de)
French (fr)
Other versions
EP1766371A2 (en
Inventor
Tom Shulte
David Cullen
Michael J Owen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pelikan Technologies Inc
Original Assignee
Pelikan Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelikan Technologies Inc filed Critical Pelikan Technologies Inc
Publication of EP1766371A2 publication Critical patent/EP1766371A2/en
Publication of EP1766371A4 publication Critical patent/EP1766371A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
EP05752221A 2004-05-20 2005-05-20 Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime Withdrawn EP1766371A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57311004P 2004-05-20 2004-05-20
US57698504P 2004-06-03 2004-06-03
PCT/US2005/017886 WO2005114185A2 (en) 2004-05-20 2005-05-20 Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime

Publications (2)

Publication Number Publication Date
EP1766371A2 EP1766371A2 (en) 2007-03-28
EP1766371A4 true EP1766371A4 (en) 2008-07-02

Family

ID=35428995

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05752221A Withdrawn EP1766371A4 (en) 2004-05-20 2005-05-20 Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime

Country Status (2)

Country Link
EP (1) EP1766371A4 (en)
WO (1) WO2005114185A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CN102914571B (en) * 2012-09-13 2014-07-09 华南师范大学 Glucose detection device and glucose detection method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556761A (en) * 1994-04-26 1996-09-17 Phillips; Kevin J. Test strip for blood glucose testing
US6208880B1 (en) * 1997-02-27 2001-03-27 Terumo Cardiovascular Systems Corporation Blood parameter measurement device
US6217828B1 (en) * 1995-11-22 2001-04-17 Terumo Cardiovascular Systems Corporation Emulsion for robust sensing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102674A1 (en) * 1987-05-20 2002-08-01 David M Anderson Stabilized microporous materials
ES2270459T3 (en) * 1996-05-01 2007-04-01 Dade Behring Marburg Gmbh CHEMOLUMINISCENT COMPOSITIONS AND ITS USE IN THE DETECTION OF HYDROGEN PEROXIDE.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556761A (en) * 1994-04-26 1996-09-17 Phillips; Kevin J. Test strip for blood glucose testing
US6217828B1 (en) * 1995-11-22 2001-04-17 Terumo Cardiovascular Systems Corporation Emulsion for robust sensing
US6208880B1 (en) * 1997-02-27 2001-03-27 Terumo Cardiovascular Systems Corporation Blood parameter measurement device

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAN H.S.O. ET AL: "A renewable glucose sensor fabricated from microemulsion polymerization of thiophene in a flow cell with application in a high-performance liquid chromatography system", JOURNAL OF ELECTROANALYTICAL CHEMISTRY AND INTERFACIALELECTRO CHEMISTRY, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/0022-0728(94)87150-7, vol. 379, no. 1-2, 12 December 1994 (1994-12-12), pages 293 - 300, XP026571304, ISSN: 0022-0728, [retrieved on 19941212] *
See also references of WO2005114185A2 *

Also Published As

Publication number Publication date
WO2005114185A2 (en) 2005-12-01
WO2005114185A3 (en) 2007-01-04
EP1766371A2 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
EP1766371A4 (en) Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime
EP1659405A4 (en) Biosensor and method of analyte measuring
HK1058703A1 (en) Analyte concentration determination meters and methods of using the same
ATE514755T1 (en) FLUORESCENT DYES FOR USE IN GLUCOSE DETECTION
EP1766349A4 (en) Dynamic chemical imaging of biological cells and other subjects
IL155313A0 (en) Devices and methods for analyte concentration determination
AU303917S (en) Analyte test meter
IL176875A0 (en) Micro-scale compact device for in vivo medical diagnosis combining optical imaging and point fluorescence spectroscopy
HK1120568A1 (en) Biosensors for detecting macromolecules and other analytes
GB2434028B (en) Simultaneous sequence analysis of amino- and carboxy-termini
ATE366930T1 (en) DEVICES FOR DETERMINING ANALYTE CONCENTRATION AND THEIR PRODUCTION AND USE
EP1592339A4 (en) Non-invasive determination of direction and rate of change of an analyte
EP1731941A4 (en) Observing device and fluorescent light observing device
AU2003277183A8 (en) Improved diagnostic fluorescence and reflectance
IL187859A0 (en) Diagnosis and prognosis of diabetes
AUPS214502A0 (en) Blood flow oxygen measurement
WO2007028163A8 (en) Biocompatible fluorescent imaging agents
EP1950556A4 (en) Substrate for analysis for use in raman spectroscopic analysis and substrate assembly for analysis
GB0424960D0 (en) Improved method of electrochemical analysis of an analyte
AU2003285340A1 (en) Agent for simultaneously dying and brightening keratin fibers
EP1900813A4 (en) Novel physiological substance nesfatin, substance relevant thereto, and use of the substances
WO2008024288A3 (en) Non-invasive methods of using spectral information in determining analyte concentrations
AU2003222031A8 (en) Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
IL160828A0 (en) Method of analyte measurement using integrated lance and strip
WO2009129472A3 (en) Methods of labeling biological samples

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061206

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20080604

17Q First examination report despatched

Effective date: 20080917

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

19U Interruption of proceedings before grant

Effective date: 20110929

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20210601

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

PUAJ Public notification under rule 129 epc

Free format text: ORIGINAL CODE: 0009425

32PN Public notification

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 2524 DATED 30/03/2022)

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20211202